Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
amgen
4
×
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
novartis
pfizer
4
×
raleigh-durham blog main
4
×
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
4
×
wisconsin blog main
wisconsin top stories
gene therapy
gilead sciences
alzheimer's disease
astrazeneca
biogen
cancer
celgene
clinical trials
cystic fibrosis
What
bio
roundup
acquisitions
biggest
ceo
drug
albert
american
annual
ash
august
biotech
blood
borne
bourla
build
busy
buy
cancers
company
company’s
conference
crispr
daniel
days
debut
decisions
devices
diego
drugs
dyne’s
fda
future
gathering
gilead
guide
hematology
host
imports
largest
Language
unset
unknown
Current search:
pfizer
×
abbvie
×
" raleigh-durham blog main "
×
" texas top stories "
×
amgen
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More
@xconomy.com
5 years ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More